FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
June 16, 2025
Inquis Medical announced today that the FDA granted expanded 510(k) clearance for its Aventus thrombectomy system.
Inquis Medical announced today that the FDA granted expanded 510(k) clearance for its Aventus thrombectomy system.
A multidisciplinary team led by Professor Li Yulong from the School of Life Sciences at Peking University has developed a far-red fluorescent dopamine (DA) probe that enables real-time, multiplex imaging of neurotransmitters in the living brain.
Devices made with cheap strips of paper have outperformed two other testing methods in detecting malaria infection in asymptomatic people in Ghana—a diagnostic advance that could accelerate efforts to eliminate the disease, researchers say.
Groundbreaking innovation redefines hearing care with intelligent, connected implant technology
GI Windows Surgical announced today that it received FDA 510(k) clearance for its Flexagon self-forming magnet technology.
AI-powered solution aims to improve image quality and efficiency in MRI workflows across Europe
InspireMD today announced it received CE Mark approval for its CGuard Prime carotid stent system for the prevention of stroke.
Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based method called “Fragle” that makes tracking cancer easier and faster using blood tests.
The BiophysicaL Immune Profiling for Infants (BLIPI) profiles an infant’s immune system in under 15 minutes, using just a single drop of blood.
TORONTO and TAIPEI, June 12, 2025 /PRNewswire/ — MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, and its Taiwanese distributor, Healtdeva Company Ltd., congratulate researchers at Shuang-Ho Hospital in Taipei, Taiwan on their publication of groundbreaking findings using MolecuLight. The clinical study demonstrates the transformative impact of MolecuLight’s i:X® device on the management of deep sternal wound infections (DSWI), showcasing significantly improved patient outcomes alongside cost savings and reduced burden on the healthcare system.